InnoTherapy Inc

SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM, which reacts immediately with blood; Endoseal for gastrointestinal bleeding; InnoSeal for surgical fields such as cardiology, radiology, and neurosurgery; Jelly Seal hemostasis and sealing products; STOP, a non-bleeding intravascular injection; Film to prevent leakage at intestinal and vascular anastomosis sites; and InnoLOCK and InTro vascular interventional procedure items. The company also operates a bio-logistics business and provides clinical trial analysis services related to new drug development, in vitro diagnostic medical device performance evaluation, and transportation of pharmaceuticals and clinical trial samples. Formerly known as InnoTherapy, Inc., it changed its name to SCL Science Inc. in March 2024. Founded in 2010, it is headquartered in Seoul, South Korea.